SIBIONICS Unveils Innovative Strategies at the 3rd AGP&DTx Summit Forum in Shenzhen

SIBIONICS Hosts the 3rd AGP & DTx Summit Forum: A Leap Towards Future Diabetes Care

On May 31, 2025, SIBIONICS commenced the 3rd AGP & DTx Summit Forum in Shenzhen, China, successfully gathering over 100 global specialists in the field of diabetes management. This forum marked a significant advancement in the dialogue around digital solutions and care strategies, fostering innovation and cooperation among experts.

The central theme of the forum revolved around "Milestones & Future Strategies of the Project on Standardizing Nursing Practices in AGP Reporting." Notably, this focus aligns with the need for more effective data handling and nurse education to empower healthcare providers in diabetes care.

Important Highlights of the Forum

A prominent feature of the event was the launch of a Continuous Glucose Monitoring (CGM) donation program in collaboration with March of Dimes China aimed at children living with Type 1 diabetes. This initiative highlights SIBIONICS’ commitment to driving better disease management practices in youth—essentially allowing these children to access necessary technology that aids in monitoring glucose levels, ultimately improving their quality of life.

Sessions Focused on Advanced Technologies

The summit comprised several parallel sessions that delved deeper into crucial topics such as CGM clinical solutions and the real-world application of AGP & DTx technologies. Key discussions included the role of CGM in enhancing treatment with innovative insulin formulations, as well as developments in artificial pancreas systems which have the potential to revolutionize diabetes treatment.

Workshops were held for nursing professionals to explore how CGM technologies can enhance clinical care in everyday scenarios, emphasizing practical application over theory.

The 'Evolution & Renewal' Exhibition

Accompanying the summit was the exhibition titled "Evolution & Renewal," which showcased the historical progress in diabetes management. It highlighted how recent advancements in CGM technology are empowering patients by allowing for more autonomy over their health.

Strengthening Global Partnerships

Alongside the forum, SIBIONICS also hosted its 2nd Global Partnership Summit, a gathering aimed at international distributors and stakeholders designed to solidify collaborations and foster global expansion strategies. This summit upheld SIBIONICS' vision to lead the way in enhancing diabetes care through innovative partnerships.

Looking Toward the Future

By combining AGP reports with cutting-edge CGM technology, SIBIONICS positions itself as a frontrunner in the evolution of diabetes care. Their commitment to transforming technology into sustainable real-world solutions is evident, as they inspire healthcare professionals while empowering patients. The ultimate vision is a future where diabetes no longer confines human potential.

About SIBIONICS

Founded in 2015, SIBIONICS has established itself as a pioneer in the medical device landscape, focusing on biosensor innovation. Headquartered in Shenzhen and Irvine, the company is dedicated to enhancing health management through integrated continuous monitoring technologies, advanced algorithms, and user-friendly software solutions. With a workforce exceeding 500 employees, 25% of whom are engaged in research and development, SIBIONICS remains focused on delivering personalized, data-driven healthcare solutions.